Mitkovski Sascha, Villemagne Victor L, Novakovic Kathy E, O'Keefe Graeme, Tochon-Danguy Henri, Mulligan Rachel S, Dickinson Kerryn L, Saunder Tim, Gregoire Marie-Claude, Bottlaender Michel, Dolle Frederic, Rowe Christopher C
Department of Nuclear Medicine and Centre for PET, Austin Hospital, Victoria 3084, Melbourne, Australia.
Nucl Med Biol. 2005 Aug;32(6):585-91. doi: 10.1016/j.nucmedbio.2005.04.013.
Neuronal nicotinic acetylcholine receptors (nAChRs), widely distributed in the human brain, are implicated in various neurophysiological processes as well as being particularly affected in neurodegenerative conditions such as Alzheimer's disease. We sought to evaluate a minimally invasive method for quantification of nAChR distribution in the normal human brain, suitable for routine clinical application, using 2[(18)F]F-A-85380 and positron emission tomography (PET).
Ten normal volunteers (four females and six males, aged 63.40+/-9.22 years) underwent a dynamic 120-min PET scan after injection of 226 MBq 2[(18)F]F-A-85380 along with arterial blood sampling. Regional binding was assessed through standardized uptake value (SUV) and distribution volumes (DV) obtained using both compartmental (DV(2CM)) and graphical analysis (DV(Logan)). A simplified approach to the estimation of DV (DV(simplified)), defined as the region-to-plasma ratio at apparent steady state (90-120 min post injection), was compared with the other quantification approaches.
DV(Logan) values were higher than DV(2CM). A strong correlation was observed between DV(simplified), DV(Logan) (r=.94) and DV(2CM) (r=.90) in cortical regions, with lower correlations in thalamus (r=.71 and .82, respectively). Standardized uptake value showed low correlation against DV(Logan) and DV(2CM).
DV(simplified) determined by the ratio of tissue to metabolite-corrected plasma using a single 90- to 120-min PET acquisition appears acceptable for quantification of cortical nAChR binding with 2[(18)F]F-A-85380 and suitable for clinical application.
神经元烟碱型乙酰胆碱受体(nAChRs)广泛分布于人类大脑中,参与多种神经生理过程,在诸如阿尔茨海默病等神经退行性疾病中尤其受到影响。我们试图评估一种微创方法,用于使用2[(18)F]F - A - 85380和正电子发射断层扫描(PET)对正常人类大脑中nAChR分布进行定量,该方法适用于常规临床应用。
10名正常志愿者(4名女性和6名男性,年龄63.40±9.22岁)在注射226 MBq 2[(18)F]F - A - 85380后进行了120分钟的动态PET扫描,并采集动脉血样。通过使用房室分析(DV(2CM))和图像分析(DV(Logan))获得的标准化摄取值(SUV)和分布容积(DV)来评估区域结合情况。将一种简化的DV估计方法(DV(简化))与其他定量方法进行比较,DV(简化)定义为注射后90 - 120分钟时的区域与血浆比值。
DV(Logan)值高于DV(2CM)。在皮质区域,DV(简化)与DV(Logan)(r = 0.94)和DV(2CM)(r = 0.90)之间观察到强相关性,在丘脑区域相关性较低(分别为r = 0.71和0.82)。标准化摄取值与DV(Logan)和DV(2CM)的相关性较低。
使用单次90至120分钟PET采集通过组织与代谢物校正血浆的比值确定的DV(简化),对于使用2[(18)F]F - A - 85380定量皮质nAChR结合似乎是可接受的,并且适用于临床应用。